Isorhamnetin Inhibits Liver Fibrosis by Reducing Autophagy and Inhibiting Extracellular Matrix Formation via the TGF-<i>β</i>1/Smad3 and TGF-<i>β</i>1/p38 MAPK PathwaysNing Liu, Yingqun Zhou|Mediators of Inflammation|2019Cited by 120